APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Haemophilia Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Haemophilia Treatment Industry Growth and Trends Forecast to 2032

Report ID 173996670120 December 2025101 pages

Choose your research edition.

Industry ResearchHaemophilia Treatment Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Haemophilia Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Haemophilia Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haemophilia Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Haemophilia Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Haemophilia Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Haemophilia Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Haemophilia Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Haemophilia Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Haemophilia Treatment include Takeda, Novo Nordisk, Roche, Pfizer, Bayer, Dimension Therapeutics, CSL Behring, Catalyst BioSciences and Aptevo Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Haemophilia Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Haemophilia Treatment market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Haemophilia Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Haemophilia Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Haemophilia Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Haemophilia Treatment Market by Company

Takeda

Novo Nordisk

Roche

Pfizer

Bayer

Dimension Therapeutics

CSL Behring

Catalyst BioSciences

Aptevo Therapeutics

Alnylam Pharmaceuticals

Haemophilia Treatment Segment by Type

Haemophilia A

Haemophilia B

Haemophilia Treatment Segment by Application

Hospital

Pharmaceutical Companies

Other

Haemophilia Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilia Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haemophilia Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilia Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Haemophilia Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Haemophilia Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Haemophilia A Table 2. Major Company of Haemophilia B Table 3. Global Haemophilia Treatment Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Haemophilia Treatment Sales by Type (2021-2026) & (k units) Table 5. Global Haemophilia Treatment Sales Market Share in Volume by Type (2021-2026) Table 6. Global Haemophilia Treatment Sales by Type (2021-2026) & (US$ Million) Table 7. Global Haemophilia Treatment Sales Market Share in Value by Type (2021-2026) Table 8. Global Haemophilia Treatment Price by Type (2021-2026) & (US$/unit) Table 9. Global Haemophilia Treatment Sales by Type (2027-2032) & (k units) Table 10. Global Haemophilia Treatment Sales Market Share in Volume by Type (2027-2032) Table 11. Global Haemophilia Treatment Sales by Type (2027-2032) & (US$ Million) Table 12. Global Haemophilia Treatment Sales Market Share in Value by Type (2027-2032) Table 13. Global Haemophilia Treatment Price by Type (2027-2032) & (US$/unit) Table 14. North America Haemophilia Treatment Sales by Type (2021-2026) & (k units) Table 15. North America Haemophilia Treatment Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Haemophilia Treatment Sales by Type (2021-2026) & (k units) Table 17. Europe Haemophilia Treatment Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Haemophilia Treatment Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Haemophilia Treatment Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Haemophilia Treatment Sales by Type (2021-2026) & (k units) Table 21. Latin America Haemophilia Treatment Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Haemophilia Treatment Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Haemophilia Treatment Sales by Type (2021-2026) & (US$ Million) Table 24. Haemophilia Treatment Industry Trends Table 25. Haemophilia Treatment Industry Drivers Table 26. Haemophilia Treatment Industry Opportunities and Challenges Table 27. Haemophilia Treatment Industry Restraints Table 28. Global Haemophilia Treatment Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Haemophilia Treatment Revenue Market Share by Company (2021-2026) Table 30. Global Haemophilia Treatment Sales by Company (2021-2026) & (k units) Table 31. Global Haemophilia Treatment Sales Share by Company (2021-2026) Table 32. Global Haemophilia Treatment Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Haemophilia Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Haemophilia Treatment Major Company Production Sites and Headquarters Table 35. Global Haemophilia Treatment Company, Product Type & Application Table 36. Global Haemophilia Treatment Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Haemophilia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Haemophilia Treatment Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Haemophilia Treatment Sales by Region (2021-2026) & (k units) Table 41. Global Haemophilia Treatment Sales Market Share in Volume by Region (2021-2026) Table 42. Global Haemophilia Treatment Sales by Region (2021-2026) & (US$ Million) Table 43. Global Haemophilia Treatment Sales Market Share in Value by Region (2021-2026) Table 44. Global Haemophilia Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Haemophilia Treatment Sales by Region (2027-2032) & (k units) Table 46. Global Haemophilia Treatment Sales Market Share in Volume by Region (2027-2032) Table 47. Global Haemophilia Treatment Sales by Region (2027-2032) & (US$ Million) Table 48. Global Haemophilia Treatment Sales Market Share in Value by Region (2027-2032) Table 49. Global Haemophilia Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Haemophilia Treatment Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Haemophilia Treatment Sales by Application (2021-2026) & (k units) Table 52. Global Haemophilia Treatment Sales Market Share in Volume by Application (2021-2026) Table 53. Global Haemophilia Treatment Sales by Application (2021-2026) & (US$ Million) Table 54. Global Haemophilia Treatment Sales Market Share in Value by Application (2021-2026) Table 55. Global Haemophilia Treatment Price by Application (2021-2026) & (US$/unit) Table 56. Global Haemophilia Treatment Sales by Application (2027-2032) & (k units) Table 57. Global Haemophilia Treatment Sales Market Share in Volume by Application (2027-2032) Table 58. Global Haemophilia Treatment Sales by Application (2027-2032) & (US$ Million) Table 59. Global Haemophilia Treatment Sales Market Share in Value by Application (2027-2032) Table 60. Global Haemophilia Treatment Price by Application (2027-2032) & (US$/unit) Table 61. North America Haemophilia Treatment Sales by Application (2021-2026) & (k units) Table 62. North America Haemophilia Treatment Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Haemophilia Treatment Sales by Application (2021-2026) & (k units) Table 64. Europe Haemophilia Treatment Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Haemophilia Treatment Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Haemophilia Treatment Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Haemophilia Treatment Sales by Application (2021-2026) & (k units) Table 68. Latin America Haemophilia Treatment Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Haemophilia Treatment Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Haemophilia Treatment Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Haemophilia Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Haemophilia Treatment Product Portfolio Table 75. Takeda Recent Development Table 76. Novo Nordisk Company Information Table 77. Novo Nordisk Business Overview Table 78. Novo Nordisk Haemophilia Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novo Nordisk Haemophilia Treatment Product Portfolio Table 80. Novo Nordisk Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche Haemophilia Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Roche Haemophilia Treatment Product Portfolio Table 85. Roche Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Haemophilia Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Pfizer Haemophilia Treatment Product Portfolio Table 90. Pfizer Recent Development Table 91. Bayer Company Information Table 92. Bayer Business Overview Table 93. Bayer Haemophilia Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Bayer Haemophilia Treatment Product Portfolio Table 95. Bayer Recent Development Table 96. Dimension Therapeutics Company Information Table 97. Dimension Therapeutics Business Overview Table 98. Dimension Therapeutics Haemophilia Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Dimension Therapeutics Haemophilia Treatment Product Portfolio Table 100. Dimension Therapeutics Recent Development Table 101. CSL Behring Company Information Table 102. CSL Behring Business Overview Table 103. CSL Behring Haemophilia Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. CSL Behring Haemophilia Treatment Product Portfolio Table 105. CSL Behring Recent Development Table 106. Catalyst BioSciences Company Information Table 107. Catalyst BioSciences Business Overview Table 108. Catalyst BioSciences Haemophilia Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Catalyst BioSciences Haemophilia Treatment Product Portfolio Table 110. Catalyst BioSciences Recent Development Table 111. Aptevo Therapeutics Company Information Table 112. Aptevo Therapeutics Business Overview Table 113. Aptevo Therapeutics Haemophilia Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Aptevo Therapeutics Haemophilia Treatment Product Portfolio Table 115. Aptevo Therapeutics Recent Development Table 116. Alnylam Pharmaceuticals Company Information Table 117. Alnylam Pharmaceuticals Business Overview Table 118. Alnylam Pharmaceuticals Haemophilia Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Alnylam Pharmaceuticals Haemophilia Treatment Product Portfolio Table 120. Alnylam Pharmaceuticals Recent Development Table 121. North America Haemophilia Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Haemophilia Treatment Sales by Country (2021-2026) & (k units) Table 123. North America Haemophilia Treatment Sales Market Share by Country (2021-2026) Table 124. North America Haemophilia Treatment Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Haemophilia Treatment Sales Market Share Forecast by Country (2027-2032) Table 126. North America Haemophilia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Haemophilia Treatment Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Haemophilia Treatment Market Share by Country (2021-2026) Table 129. North America Haemophilia Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Haemophilia Treatment Market Share Forecast by Country (2027-2032) Table 131. Europe Haemophilia Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Haemophilia Treatment Sales by Country (2021-2026) & (k units) Table 133. Europe Haemophilia Treatment Sales Market Share by Country (2021-2026) Table 134. Europe Haemophilia Treatment Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Haemophilia Treatment Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Haemophilia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Haemophilia Treatment Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Haemophilia Treatment Market Share by Country (2021-2026) Table 139. Europe Haemophilia Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Haemophilia Treatment Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Haemophilia Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Haemophilia Treatment Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Haemophilia Treatment Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Haemophilia Treatment Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Haemophilia Treatment Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Haemophilia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Haemophilia Treatment Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Haemophilia Treatment Market Share by Country (2021-2026) Table 149. Asia-Pacific Haemophilia Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Haemophilia Treatment Market Share Forecast by Country (2027-2032) Table 151. Latin America Haemophilia Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Haemophilia Treatment Sales by Country (2021-2026) & (k units) Table 153. Latin America Haemophilia Treatment Sales Market Share by Country (2021-2026) Table 154. Latin America Haemophilia Treatment Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Haemophilia Treatment Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Haemophilia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Haemophilia Treatment Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Haemophilia Treatment Market Share by Country (2021-2026) Table 159. Latin America Haemophilia Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Haemophilia Treatment Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Haemophilia Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Haemophilia Treatment Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Haemophilia Treatment Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Haemophilia Treatment Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Haemophilia Treatment Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Haemophilia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Haemophilia Treatment Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Haemophilia Treatment Market Share by Country (2021-2026) Table 169. Middle East and Africa Haemophilia Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Haemophilia Treatment Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Haemophilia Treatment Distributors List Table 174. Haemophilia Treatment Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Haemophilia Treatment Image Figure 2. Global Haemophilia Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haemophilia Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Haemophilia Treatment Sales (2021-2032) & (k units) Figure 5. Haemophilia A Image Figure 6. Global Haemophilia A Sales YoY Growth (2021-2032) & (k units) Figure 7. Haemophilia B Image Figure 8. Global Haemophilia B Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Haemophilia Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Haemophilia Treatment Market Share by Type 2025 VS 2032 Figure 11. North America Haemophilia Treatment Sales Market Share in Volume by Type in 2025 Figure 12. North America Haemophilia Treatment Sales Market Share in Value by Type in 2025 Figure 13. Europe Haemophilia Treatment Sales Market Share in Volume by Type in 2025 Figure 14. Europe Haemophilia Treatment Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Haemophilia Treatment Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Haemophilia Treatment Sales Market Share in Value by Type in 2025 Figure 17. Latin America Haemophilia Treatment Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Haemophilia Treatment Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Haemophilia Treatment Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Haemophilia Treatment Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Haemophilia Treatment Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Pharmaceutical Companies Image Figure 26. Global Pharmaceutical Companies Sales YoY Growth (2021-2032) & (k units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Haemophilia Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Haemophilia Treatment Market Share by Application 2025 VS 2032 Figure 31. North America Haemophilia Treatment Sales Market Share in Volume by Application in 2025 Figure 32. North America Haemophilia Treatment Sales Market Share in Value by Application in 2025 Figure 33. Europe Haemophilia Treatment Sales Market Share in Volume by Application in 2025 Figure 34. Europe Haemophilia Treatment Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Haemophilia Treatment Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Haemophilia Treatment Sales Market Share in Value by Application in 2025 Figure 37. Latin America Haemophilia Treatment Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Haemophilia Treatment Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Haemophilia Treatment Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Haemophilia Treatment Sales Market Share in Value by Application in 2025 Figure 41. North America Haemophilia Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Haemophilia Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Haemophilia Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Haemophilia Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Haemophilia Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Haemophilia Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Haemophilia Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Haemophilia Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Haemophilia Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Haemophilia Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Haemophilia Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Haemophilia Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Haemophilia Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Haemophilia Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Haemophilia Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Haemophilia Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Haemophilia Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Haemophilia Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Haemophilia Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Haemophilia Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Haemophilia Treatment Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Haemophilia Treatment Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Haemophilia A
  • Haemophilia B
Applications
  • Hospital
  • Pharmaceutical Companies
  • Other
Companies covered
  • Takeda
  • Novo Nordisk
  • Roche
  • Pfizer
  • Bayer
  • Dimension Therapeutics
  • CSL Behring
  • Catalyst BioSciences
  • Aptevo Therapeutics
  • Alnylam Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Haemophilia Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Haemophilia Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Haemophilia Treatment Market by Type
  6. 1.3.1 Haemophilia A
  7. 1.3.2 Haemophilia B
  8. 1.4 Global Haemophilia Treatment Market Size by Type
  9. 1.4.1 Global Haemophilia Treatment Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Haemophilia Treatment Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Haemophilia Treatment Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Haemophilia Treatment Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Haemophilia Treatment Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Haemophilia Treatment Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Haemophilia Treatment Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Haemophilia Treatment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Haemophilia Treatment Industry Trends
  2. 2.2 Haemophilia Treatment Industry Drivers
  3. 2.3 Haemophilia Treatment Industry Opportunities and Challenges
  4. 2.4 Haemophilia Treatment Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Haemophilia Treatment Revenue (2021-2026)
  2. 3.2 Global Top Players by Haemophilia Treatment Sales (2021-2026)
  3. 3.3 Global Top Players by Haemophilia Treatment Price (2021-2026)
  4. 3.4 Global Haemophilia Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Haemophilia Treatment Major Company Production Sites & Headquarters
  6. 3.6 Global Haemophilia Treatment Company, Product Type & Application
  7. 3.7 Global Haemophilia Treatment Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Haemophilia Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Haemophilia Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Haemophilia Treatment Tier 1, Tier 2, and Tier 3
4 Haemophilia Treatment Regional Status and Outlook
  1. 4.1 Global Haemophilia Treatment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Haemophilia Treatment Historic Market Size by Region
  3. 4.2.1 Global Haemophilia Treatment Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Haemophilia Treatment Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Haemophilia Treatment Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Haemophilia Treatment Forecasted Market Size by Region
  7. 4.3.1 Global Haemophilia Treatment Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Haemophilia Treatment Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Haemophilia Treatment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Haemophilia Treatment by Application
  1. 5.1 Haemophilia Treatment Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmaceutical Companies
  4. 5.1.3 Other
  5. 5.2 Global Haemophilia Treatment Market Size by Application
  6. 5.2.1 Global Haemophilia Treatment Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Haemophilia Treatment Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Haemophilia Treatment Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Haemophilia Treatment Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Haemophilia Treatment Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Haemophilia Treatment Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Haemophilia Treatment Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Haemophilia Treatment Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Haemophilia Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Haemophilia Treatment Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Haemophilia Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Haemophilia Treatment Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Haemophilia Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche Haemophilia Treatment Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Haemophilia Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Haemophilia Treatment Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Haemophilia Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer Haemophilia Treatment Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Dimension Therapeutics
  32. 6.6.1 Dimension Therapeutics Company Information
  33. 6.6.2 Dimension Therapeutics Business Overview
  34. 6.6.3 Dimension Therapeutics Haemophilia Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Dimension Therapeutics Haemophilia Treatment Product Portfolio
  36. 6.6.5 Dimension Therapeutics Recent Developments
  37. 6.7 CSL Behring
  38. 6.7.1 CSL Behring Company Information
  39. 6.7.2 CSL Behring Business Overview
  40. 6.7.3 CSL Behring Haemophilia Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CSL Behring Haemophilia Treatment Product Portfolio
  42. 6.7.5 CSL Behring Recent Developments
  43. 6.8 Catalyst BioSciences
  44. 6.8.1 Catalyst BioSciences Company Information
  45. 6.8.2 Catalyst BioSciences Business Overview
  46. 6.8.3 Catalyst BioSciences Haemophilia Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Catalyst BioSciences Haemophilia Treatment Product Portfolio
  48. 6.8.5 Catalyst BioSciences Recent Developments
  49. 6.9 Aptevo Therapeutics
  50. 6.9.1 Aptevo Therapeutics Company Information
  51. 6.9.2 Aptevo Therapeutics Business Overview
  52. 6.9.3 Aptevo Therapeutics Haemophilia Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Aptevo Therapeutics Haemophilia Treatment Product Portfolio
  54. 6.9.5 Aptevo Therapeutics Recent Developments
  55. 6.10 Alnylam Pharmaceuticals
  56. 6.10.1 Alnylam Pharmaceuticals Company Information
  57. 6.10.2 Alnylam Pharmaceuticals Business Overview
  58. 6.10.3 Alnylam Pharmaceuticals Haemophilia Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Alnylam Pharmaceuticals Haemophilia Treatment Product Portfolio
  60. 6.10.5 Alnylam Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Haemophilia Treatment Sales by Country
  2. 7.1.1 North America Haemophilia Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Haemophilia Treatment Sales by Country (2021-2026)
  4. 7.1.3 North America Haemophilia Treatment Sales Forecast by Country (2027-2032)
  5. 7.2 North America Haemophilia Treatment Market Size by Country
  6. 7.2.1 North America Haemophilia Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Haemophilia Treatment Market Size by Country (2021-2026)
  8. 7.2.3 North America Haemophilia Treatment Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Haemophilia Treatment Sales by Country
  2. 8.1.1 Europe Haemophilia Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Haemophilia Treatment Sales by Country (2021-2026)
  4. 8.1.3 Europe Haemophilia Treatment Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Haemophilia Treatment Market Size by Country
  6. 8.2.1 Europe Haemophilia Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Haemophilia Treatment Market Size by Country (2021-2026)
  8. 8.2.3 Europe Haemophilia Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Haemophilia Treatment Sales by Country
  2. 9.1.1 Asia-Pacific Haemophilia Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Haemophilia Treatment Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Haemophilia Treatment Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Haemophilia Treatment Market Size by Country
  6. 9.2.1 Asia-Pacific Haemophilia Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Haemophilia Treatment Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Haemophilia Treatment Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Haemophilia Treatment Sales by Country
  2. 10.1.1 South America Haemophilia Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Haemophilia Treatment Sales by Country (2021-2026)
  4. 10.1.3 South America Haemophilia Treatment Sales Forecast by Country (2027-2032)
  5. 10.2 South America Haemophilia Treatment Market Size by Country
  6. 10.2.1 South America Haemophilia Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Haemophilia Treatment Market Size by Country (2021-2026)
  8. 10.2.3 South America Haemophilia Treatment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Haemophilia Treatment Sales by Country
  2. 11.1.1 Middle East and Africa Haemophilia Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Haemophilia Treatment Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Haemophilia Treatment Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Haemophilia Treatment Market Size by Country
  6. 11.2.1 Middle East and Africa Haemophilia Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Haemophilia Treatment Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Haemophilia Treatment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Haemophilia Treatment Value Chain Analysis
  2. 12.1.1 Haemophilia Treatment Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Haemophilia Treatment Production Mode & Process
  7. 12.2 Haemophilia Treatment Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Haemophilia Treatment Distributors
  10. 12.2.3 Haemophilia Treatment Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst